1. Home
  2. TNXP vs WKHS Comparison

TNXP vs WKHS Comparison

Compare TNXP & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • WKHS
  • Stock Information
  • Founded
  • TNXP 2007
  • WKHS 2007
  • Country
  • TNXP United States
  • WKHS United States
  • Employees
  • TNXP N/A
  • WKHS N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • TNXP Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • TNXP 19.5M
  • WKHS 19.5M
  • IPO Year
  • TNXP N/A
  • WKHS N/A
  • Fundamental
  • Price
  • TNXP $0.20
  • WKHS $1.04
  • Analyst Decision
  • TNXP Strong Buy
  • WKHS Sell
  • Analyst Count
  • TNXP 2
  • WKHS 3
  • Target Price
  • TNXP $53.50
  • WKHS $5.75
  • AVG Volume (30 Days)
  • TNXP 51.5M
  • WKHS 5.0M
  • Earning Date
  • TNXP 11-12-2024
  • WKHS 11-19-2024
  • Dividend Yield
  • TNXP N/A
  • WKHS N/A
  • EPS Growth
  • TNXP N/A
  • WKHS N/A
  • EPS
  • TNXP N/A
  • WKHS N/A
  • Revenue
  • TNXP $11,291,000.00
  • WKHS $9,097,780.00
  • Revenue This Year
  • TNXP $62.53
  • WKHS N/A
  • Revenue Next Year
  • TNXP $26.17
  • WKHS $236.05
  • P/E Ratio
  • TNXP N/A
  • WKHS N/A
  • Revenue Growth
  • TNXP 183.05
  • WKHS N/A
  • 52 Week Low
  • TNXP $0.12
  • WKHS $0.57
  • 52 Week High
  • TNXP $22.08
  • WKHS $8.78
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 66.43
  • WKHS 52.28
  • Support Level
  • TNXP $0.17
  • WKHS $0.88
  • Resistance Level
  • TNXP $0.28
  • WKHS $1.42
  • Average True Range (ATR)
  • TNXP 0.02
  • WKHS 0.21
  • MACD
  • TNXP 0.01
  • WKHS -0.01
  • Stochastic Oscillator
  • TNXP 44.53
  • WKHS 25.61

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: